Alcinous Pharmaceuticals logo

Alcinous Pharmaceuticals

1 employees · est. 2016 · United States

VS
Vernalis logo

Vernalis

We develop and apply fragment and structure-based methods to solve problems in drug discovery

253 employees · est. 1997 · Cambridge, United Kingdom

Vernalis is the older company (2016 vs 1997); Vernalis is the larger of the two.

Side-by-Side Comparison

Alcinous Pharmaceuticals Vernalis
Founded
2016 1997 older
Headquarters
United States Cambridge, United Kingdom
Employees
1 253 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
Seed Series Unknown
Total Funding
$600.00K Not tracked yet
Funding Rounds
1 1
Services
Not tracked yet Drug Discovery Collaboration, Protein Production, Hit Identification and Validation, Lead Optimization, Biophysics and Structural Biology, Chemical Series Evolution
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Firms, Research Institutions, Drug Discovery Teams
Taxonomy
Therapeutics, Aggressive Cancers, Drug Discovery, Molecular Design, Pharmaceuticals, Oncology, Pathologies, Protein Targets, Innovation, Start-up, Research, University Spin-off, PhD Founded, Science-driven Fragment-based Drug Discovery, Structure-based Methods, Oncology Drug Discovery, Neurodegeneration Targets, Anti-infectives, Inflammation Drug Discovery, Structural Biology, Biophysics, Medicinal Chemistry, Molecular Modelling, Protein-protein Interactions, Development Of Clinical Candidates, Kinases And ATPases, GPCRs, Shared-risk Research Collaborations
Website
alcinouspharmaceuticals.com vernalis.com
Alcinous Pharmaceuticals logo

About Alcinous Pharmaceuticals

Alcinous Pharmaceuticals is a biotechnology and pharmaceutical company, established in 2016 by three PhD students at the University of Rhode Island. The company is focused on creating therapeutics for aggressive cancers through a novel drug discovery pipeline. Their approach involves leveraging an i...

Vernalis logo

About Vernalis

Vernalis, founded in 1997, is a UK-based company operating at the forefront of the Biotechnology and Pharmaceutical industries. With a commitment to advancing drug discovery, their slogan encapsulates their mission: "We develop and apply fragment and structure-based methods to solve problems in drug...

We will tell you when either one moves

BounceWatch watches Alcinous Pharmaceuticals and Vernalis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alcinous Pharmaceutica... and Vernalis — by email.

Frequently Asked Questions

Alcinous Pharmaceuticals. Vernalis — We develop and apply fragment and structure-based methods to solve problems in drug discovery. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alcinous Pharmaceuticals has raised $600.00K while Vernalis has raised undisclosed funding.
Alcinous Pharmaceuticals and Vernalis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alcinous Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alcinous Pharmaceuticals on 11 Sep 2024, and Vernalis on 2 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy